ANI Pharmaceuticals, Inc.
NasdaqGM:ANIP
$ 61.43
$-2.34 (-3.67%)
$ 61.43
$-2.34 (-3.67%)
End-of-day quote: 05/17/2024

ANI Pharmaceuticals financials at a glance

The revenue of ANI Pharmaceuticals is reported as 0.48682 billion Dollars in the fiscal year 2023. The earnings were 4.71 Dollars per share in 2023, which was 246.32 higher than 2022. And about 0.11009 billion Dollars are reported as free cash flow in the financials of ANI Pharmaceuticals 2023. No dividends were paid to the shareholders of the ANI Pharmaceuticals stock NasdaqGM:ANIP in the financial year 2023.

$486.82M
Revenue
$4.71
Earnings Per Share
62.71%
Gross Margin %
$82.79M
Free Cash Flow
Revenue
486.82
Earnings Per Share
4.71
Gross Margin %
62.71
Free Cash Flow
82.79

Financials

Year Year TTM 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013
Rev. Revenue N/A $486.82M $316.39M $216.14M $208.48M $206.55M $201.58M $176.84M $128.62M $76.32M $55.97M $30.08M
GM % Gross Margin % 62.23% 62.71% 56.13% 53.45% 60.26% 71.65% 63.77% 55.31% 66.66% 83.37% 79.50% 66.84%
OM Operating Margin 9.02% 10.17% -8.13% -8.68% -2.29% 11.29% 17.54% 16.53% 26.41% 42.84% 38.07% 21.27%
EPS Earnings Per Share $0.57 $4.71 $1.36 $3.20 $3.50 $5.06 $5.07 $3.91 $2.96 $2.72 $1.48 $-0.96
Div. Dividends N/A $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
PR % Payout Ratio % 0 0 0 0 0 0 0 0 0 0 0 0
Sha. Shares N/AM 19.72M 16.35M 16.55M 12M 11.9M 11.85M 11.65M 11.59M 11.45M 11.39M 9.64M
OCF Operating Cash Flow N/A $118.96M $-31.20M $3.32M $15.27M $45.63M $67.07M $0.00M $27.47M $17.26M $22.03M $-5.48M
FCF Free Cash Flow N/A $82.79M $-40.08M $0.77M $9.13M $38.99M $45.24M $-74.81M $22.90M $15.08M $20.91M $-5.67M
FCFS Free Cash Flow Per Share $2.96 $5.49 $-3.03 $-1.63 $-4.43 $1.53 $4.81 $-5.94 $-10.62 $-1.36 $-1.25 $-1.12